In focus · trending topic

farnesylation

2 stories · following the connections

Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018

By Nasdaq OMXApr 9, 2018, 11:30 AM UTC

Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia

By Nasdaq OMXJan 17, 2017, 12:30 PM UTC